Pecoma

• CLINICAL_TRIALS trial_result · 2025-02-17
  Clinical Trial Update: Nivolumab (Opdivo®) Plus ABI-009 (Nab-rapamycin) for Advanced Sarcoma and Certain Cancers [Phase 1, Phase 2]

  Phase 1/2 trial update evaluating nivolumab plus ABI-009 (nab-rapamycin) in patients with advanced sarcoma and selected cancers, with result…

• CLINICAL_TRIALS trial_result · 2016-08-22
  Clinical Trial Update: Evaluation of New Biomarkers Predictive of Efficacy Betablockers in PEComa and Vascular Pediatric Tumors

  A completed clinical trial from University Hospital, Bordeaux evaluating biomarkers that predict the efficacy of beta-blockers in PEComa and…